Surgical Innovations Group PLC Issue of Equity (8592R)
September 26 2017 - 6:29AM
UK Regulatory
TIDMSUN
RNS Number : 8592R
Surgical Innovations Group PLC
26 September 2017
Surgical Innovations Group plc
(the "Company")
Issue of Shares
Surgical Innovations Group plc (AIM: SUN) has issued and
allotted a total of 198,830 ordinary shares of 1p each ("Shares")
at a price of 3.675p per share to Nigel Rogers, Executive Chairman,
and Michael McMahon, Non-Executive Director in lieu of remuneration
for the third quarter of 2017.
Details of the Shares issued and the resulting holdings of each
of the directors are as follows:
Director Shares Resulting Percentage
issued holding of enlarged
share capital
Nigel Rogers 117,197 4,921,060 0.63%
Michael McMahon 81,633 18,586,370 2.38%
The issue price was set at the closing price on the date of the
Company's payroll in September.
Application will be made for 198,830 Shares to be admitted to
trading on AIM ("Admission") which is expected to take place on 2
October 2017.
Following Admission, the total number of ordinary shares in
issue will be 780,463,418 with each share carrying the right to one
vote. The above figure may be used by shareholders as the
denominator for the purposes of calculating their holding in the
Company under the Disclosure Guidance and Transparency Rules.
For further information please contact:
Surgical Innovations Group www.sigroupplc.com
plc
Nigel Rogers, Executive Tel: 0113 230 7597
Chairman
Melanie Ross, COO & CFO
WH Ireland Limited (NOMAD Tel: 0113 394 6600
& Broker)
Tim Feather
Walbrook PR (Financial PR Tel: 020 7933 8780 or
& Investor Relations) si@walbrookpr.com
Paul McManus Mob: 07980 541 893
Lianne Cawthorne Mob: 07584 391 303
This information is provided by RNS
The company news service from the London Stock Exchange
END
IOEFQLFLDKFLBBD
(END) Dow Jones Newswires
September 26, 2017 07:29 ET (11:29 GMT)
Surgical Innovations (LSE:SUN)
Historical Stock Chart
From Apr 2024 to May 2024
Surgical Innovations (LSE:SUN)
Historical Stock Chart
From May 2023 to May 2024